These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial. Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543 [TBL] [Abstract][Full Text] [Related]
5. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. Robles GI; Singh-Franco D; Ghin HL Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928 [TBL] [Abstract][Full Text] [Related]
6. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918 [TBL] [Abstract][Full Text] [Related]
8. Changes in health-related quality of life with smoking cessation treatment. Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658 [TBL] [Abstract][Full Text] [Related]
9. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Hays JT; Hurt RD; Rigotti NA; Niaura R; Gonzales D; Durcan MJ; Sachs DP; Wolter TD; Buist AS; Johnston JA; White JD Ann Intern Med; 2001 Sep; 135(6):423-33. PubMed ID: 11560455 [TBL] [Abstract][Full Text] [Related]
10. Use of sustained-release bupropion in specific patient populations for smoking cessation. Tonstad S Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934 [TBL] [Abstract][Full Text] [Related]
11. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977 [TBL] [Abstract][Full Text] [Related]
12. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Croghan IT; Hurt RD; Dakhil SR; Croghan GA; Sloan JA; Novotny PJ; Rowland KM; Bernath A; Loots ML; Le-Lindqwister NA; Tschetter LK; Garneau SC; Flynn KA; Ebbert LP; Wender DB; Loprinzi CL Mayo Clin Proc; 2007 Feb; 82(2):186-95. PubMed ID: 17290726 [TBL] [Abstract][Full Text] [Related]
15. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR; JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793 [TBL] [Abstract][Full Text] [Related]
17. Paths to tobacco abstinence: A repeated-measures latent class analysis. McCarthy DE; Ebssa L; Witkiewitz K; Shiffman S J Consult Clin Psychol; 2015 Aug; 83(4):696-708. PubMed ID: 25867447 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR; JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of bupropion alone and in combination with nicotine gum. Piper ME; Federman EB; McCarthy DE; Bolt DM; Smith SS; Fiore MC; Baker TB Nicotine Tob Res; 2007 Sep; 9(9):947-54. PubMed ID: 17763111 [TBL] [Abstract][Full Text] [Related]
20. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Rose JE; Behm FM Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]